Brimonidine/timolol
| Combination of | |
|---|---|
| Brimonidine | α2 adrenergic agonist |
| Timolol | Beta blocker |
| Clinical data | |
| Trade names | Combigan |
| AHFS/Drugs.com | Professional Drug Facts |
| Pregnancy category |
|
| Routes of administration | Eye drops |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| KEGG | |
| CompTox Dashboard (EPA) | |
Brimonidine/timolol, sold under the brand name Combigan among others, is a fixed-dose combination medication eye drop used for the treatment of glaucoma.[1] It is a combination of brimonidine (an α2 adrenergic agonist) and timolol (a β adrenergic blocker).[1]
In 2020, it was the 256th most commonly prescribed medication in the United States, with more than 1 million prescriptions.[2][3]
- ^ a b c "Combigan- brimonidine tartrate, timolol maleate solution/ drops". DailyMed. 1 October 2015. Retrieved 12 November 2022.
- ^ "The Top 300 of 2020". ClinCalc. Retrieved 7 October 2022.
- ^ "Brimonidine; Timolol - Drug Usage Statistics". ClinCalc. Retrieved 7 October 2022.